Lynne Marie Sullivan
CIK 1727640 · CFO & Head of Corp. Dev. · last filed 2026-06-11
Lynne Marie Sullivan is a CFO & Head of Corp. Dev. who has filed 38 SEC Form 4 insider transactions across 5 companies since 2018. The most recent filing, for SLDB, was dated Jun 11, 2026. Across all open-market trades the lifetime net is +$26.3K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
5
38
$26.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SLDB | Director | — | $8.56 | — | $0 | 11 | 2026-06-11 |
| Unity Biotechnology, Inc. (UBX) Delisted | CFO & Head of Corp. Dev. | 98,905 | $0.20 | $19.8K | -$23.7K | 13 | 2025-04-03 |
| Inozyme Pharma, Inc. (INZY) Delisted | Director | — | $4.00 | — | $0 | 5 | 2024-06-20 |
| BiomX Inc. (PHGE.WS) Delisted | Director | 12,500 | $0.01 | $110 | $50.0K | 5 | 2023-03-03 |
| Adicet Bio, Inc. (TORC) Delisted | Director | — | — | — | $0 | 2 | 2020-06-05 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | SLDB | Grant (A) | — | $0 | EDGAR |
| 2025-07-03 | — | Disp (D) | — | $0 | |
| 2025-06-13 | SLDB | Grant (A) | — | $0 | EDGAR |
| 2025-04-03 | Unity Biotechnology, Inc. (UBX) Delisted | Sell (S) | −21,867 | -$22.5K | EDGAR |
| 2025-04-03 | Unity Biotechnology, Inc. (UBX) Delisted | Notice (144) | −21,867 | -$22.4K | EDGAR |
| 2025-03-31 | Unity Biotechnology, Inc. (UBX) Delisted | Grant (A) | +65,000 | $0 | EDGAR |
| 2025-02-05 | Unity Biotechnology, Inc. (UBX) Delisted | Sell (S) | −153 | -$341 | EDGAR |
| 2025-01-23 | Unity Biotechnology, Inc. (UBX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-11-06 | Unity Biotechnology, Inc. (UBX) Delisted | Sell (S) | −136 | -$175 | EDGAR |
| 2024-08-06 | Unity Biotechnology, Inc. (UBX) Delisted | Sell (S) | −139 | -$213 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.